Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics
- 21 November 2008
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 81 (2) , 141-146
- https://doi.org/10.1016/j.antiviral.2008.10.007
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutantsAntiviral Research, 2008
- The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and AntiretroviralAntimicrobial Agents and Chemotherapy, 2008
- Clinical Significance of Human Immunodeficiency Virus Type 1 Replication FitnessClinical Microbiology Reviews, 2007
- Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Genetic Analyses of DNA-Binding Mutants in the Catalytic Core Domain of Human Immunodeficiency Virus Type 1 IntegraseJournal of Virology, 2005
- Analysis of Early Human Immunodeficiency Virus Type 1 DNA Synthesis by Use of a New Sensitive Assay for Quantifying Integrated ProvirusJournal of Virology, 2003
- A quantitative assay for HIV DNA integration in vivoNature Medicine, 2001
- Small Amino Acid Changes in the V3 Loop of Human Immunodeficiency Virus Type 2 Determines the Coreceptor Usage for CXCR4 and CCR5Virology, 1999
- The Mobility of an HIV-1 Integrase Active Site Loop Is Correlated with Catalytic Activity,Biochemistry, 1999